Discovery of serum proteomic biomarkers for prediction of response to infliximab (a monoclonal anti-TNF antibody) treatment in rheumatoid arthritis: An exploratory analysis-Reference-Cited by-同舟云学术

Discovery of serum proteomic biomarkers for prediction of response to infliximab (a monoclonal anti-TNF antibody) treatment in rheumatoid arthritis: An exploratory analysis

Published:2012-12 Issue: Volume:77 Page:372-382
ISSN:1874-3919
Container-title:Journal of Proteomics
language:en
Short-container-title:Journal of Proteomics

Author:

Ortea Ignacio,Roschitzki Bernd,Ovalles Juan Gabriel,Longo Javier López,de la Torre Inmaculada,González Isidoro,Gómez-Reino Juan J.,González Antonio

Publisher

Elsevier BV

Subject

Biochemistry,Biophysics

Reference80 articles.

1. Rheumatoid arthritis;Scott;Lancet,2010

2. Optimizing anti-TNF treatment in inflammatory bowel disease;Rutgeers;Gastroenterology,2004

3. The need for personalised medicine for rheumatoid arthritis;Isaacs;Ann Rheum Dis,2011

4. Optimising treatment in rheumatoid arthritis: a review of potencial biological markers of response;Emery;Ann Rheum Dis,2011

5. Protein biochip array technology for cytokine profiling predicts etanercept responsiveness in rheumatoid arthritis;Fabre;Clin Exp Immunol,2008

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Naïve Inflammatory Proteome Profiles of Glucocorticoid Responsive Polymyalgia Rheumatica and Rheumatic Arthritis Patients—Links to Triggers and Proteomic Manifestations;Journal of Personalized Medicine;2024-04-25

2. Pharmacoproteomics and Rheumatoid Arthritis Management;Pharmacoproteomics;2024

3. Gene Ontology Analysis Highlights Biological Processes Influencing Non-Response to Anti-TNF Therapy in Rheumatoid Arthritis;Biomedicines;2022-07-27

4. ATRPred: A machine learning based tool for clinical decision making of anti-TNF treatment in rheumatoid arthritis patients;PLOS Computational Biology;2022-07-05

5. iTRAQ and PRM-Based Proteomic Analysis Provides New Insights into Mechanisms of Response to Triple Therapy in Patients with Rheumatoid Arthritis;Journal of Inflammation Research;2021-12